Study of NRG4 in Diabetes with and without Obesity
Part of Hormones & metabolism clinical trials.
This study looks at a protein called NRG4 in people with type 2 diabetes, comparing those who are obese and those who are not. It aims to see if NRG4 levels differ, which could help understand diabetes better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have type 2 diabetes that was recently diagnosed and you haven't taken diabetes medication yet, OR you have been treated for type 2 diabetes for at least 6 months.
- Your body mass index (BMI) is either greater than 30 (obese) or less than 25 (not obese).
- You are not pregnant or breastfeeding.
- You do not have an active infection, inflammatory disease, or rheumatologic condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults over time to understand how weight and body chemistry relate to insulin resistance. It may help researchers learn why insulin resistance happens and what could prevent or improve it.
This trial is checking how well blood sugar is controlled in adults recently diagnosed with type 2 diabetes (within the last 3 months). It aims to see if current treatments or lifestyle changes are working and may help guide future care.
This study looks at how fat is processed in the body for people with different health conditions, including obesity and type 2 diabetes. It aims to find new ways to improve treatment by understanding these differences.
This is an observational study that follows generally healthy adults to understand how inflammation, diabetes (type 2), and weight/metabolic health relate to each other. It may help researchers figure out why different groups (including different ethnic backgrounds) have different health risks.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This study tests a new medicine (NNC9733-0001) to see how it works in healthy people and in people with type 2 diabetes. It helps researchers understand safety and how the body processes the drug.
Hear when a new Obesity Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.